Sionna Therapeutics (SION) News Today $11.53 -0.45 (-3.76%) As of 12:28 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Sionna Therapeutics (NASDAQ:SION) Trading 4.5% Higher - Still a Buy?Sionna Therapeutics (NASDAQ:SION) Stock Price Up 4.5% - Here's WhyMarch 26 at 2:45 PM | marketbeat.comSionna Therapeutics (NASDAQ:SION) Shares Down 4.2% - What's Next?Sionna Therapeutics (NASDAQ:SION) Trading Down 4.2% - Here's What HappenedMarch 25 at 3:38 PM | marketbeat.comTD Cowen Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)March 23, 2025 | markets.businessinsider.comSionna Therapeutics Inc.March 23, 2025 | wsj.comSionna Therapeutics (NASDAQ:SION) Reaches New 12-Month Low Following Weak EarningsSionna Therapeutics (NASDAQ:SION) Reaches New 1-Year Low Following Weak EarningsMarch 22, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Reaches New 1-Year Low on Disappointing EarningsMarch 22, 2025 | americanbankingnews.comSionna Therapeutics (NASDAQ:SION) Shares Gap Up - Should You Buy?Sionna Therapeutics (NASDAQ:SION) Shares Gap Up - Should You Buy?March 21, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Posts Quarterly Earnings Results, Misses Expectations By $0.70 EPSSionna Therapeutics (NASDAQ:SION - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($3.38) EPS for the quarter, missing analysts' consensus estimates of ($2.68) by ($0.70).March 21, 2025 | marketbeat.comSionna Therapeutics, Inc.: Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 21, 2025 | finanznachrichten.deSionna Therapeutics sees cash runway into 2028March 21, 2025 | markets.businessinsider.comSionna Therapeutics reports Q4 EPS ($3.38) vs. ($3.93) last yearMarch 21, 2025 | markets.businessinsider.comSionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 20, 2025 | globenewswire.comSION Sionna Therapeutics, Inc.March 19, 2025 | seekingalpha.comSionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last MonthMarch 15, 2025 | insidermonkey.comSionna Therapeutics (NASDAQ:SION) Stock Price Down 3.5% - Here's What HappenedSionna Therapeutics (NASDAQ:SION) Stock Price Down 3.5% - Here's WhyMarch 15, 2025 | marketbeat.comTop 10 Insider Purchases Last MonthMarch 14, 2025 | insidermonkey.comSionna Therapeutics (NASDAQ:SION) Trading Up 10.2% - Should You Buy?Sionna Therapeutics (NASDAQ:SION) Trading Up 10.2% - What's Next?March 12, 2025 | marketbeat.comSionna Therapeutics, Inc.'s Quiet Period To Expire on March 19th (NASDAQ:SION)Sionna Therapeutics' (NASDAQ:SION - Get Free Report) quiet period will end on Wednesday, March 19th. Sionna Therapeutics had issued 10,588,233 shares in its public offering on February 7th. The total size of the offering was $190,588,194 based on an initial share price of $18.00. During Sionna Therapeutics' quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.March 12, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Stock Price Down 5.6% - Here's WhySionna Therapeutics (NASDAQ:SION) Trading Down 5.6% - Here's WhyMarch 7, 2025 | marketbeat.comIs Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently?March 7, 2025 | msn.comSionna Therapeutics (NASDAQ:SION) Trading Up 5.6% - Here's WhySionna Therapeutics (NASDAQ:SION) Trading 5.6% Higher - Here's What HappenedMarch 4, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Coverage Initiated by Analysts at TD CowenTD Cowen started coverage on shares of Sionna Therapeutics in a report on Tuesday. They issued a "buy" rating on the stock.March 4, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Now Covered by Stifel NicolausStifel Nicolaus started coverage on shares of Sionna Therapeutics in a research note on Tuesday. They issued a "buy" rating and a $32.00 price target on the stock.March 4, 2025 | marketbeat.comSionna Therapeutics (NASDAQ:SION) Coverage Initiated at GuggenheimGuggenheim initiated coverage on Sionna Therapeutics in a report on Tuesday. They issued a "buy" rating and a $45.00 price objective for the company.March 4, 2025 | marketbeat.comSionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending RecentlyMarch 3, 2025 | insidermonkey.comSionna Therapeutics to Present at the 45th Annual TD Cowen Health Care ConferenceFebruary 24, 2025 | globenewswire.com Remove Ads Get Sionna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SION and its competitors with MarketBeat's FREE daily newsletter. Email Address SION Media Mentions By Week SION Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SION News Sentiment▼-0.150.78▲Average Medical News Sentiment SION News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SION Articles This Week▼96▲SION Articles Average Week Remove Ads Get Sionna Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SION and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IBRX News EWTX News MIRM News BEAM News CNTA News KYMR News BLTE News DNLI News CGON News ARWR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SION) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredTrump… a socialist? Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs Trump Secretly Pumping Up Elon’s New AI Venture?President Trump just bought a Tesla - right in front of the White House. But what most investors don't real...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sionna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sionna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.